Jazz Pharmaceuticals ROI - Return on Investment 2010-2024 | JAZZ

Jazz Pharmaceuticals return on investment for the quarter ending September 30, 2024 was 5.31.

  • Jazz Pharmaceuticals average return on investment for 2023 was 0.76, a 139.79% increase from 2022.
  • Jazz Pharmaceuticals average return on investment for 2022 was -1.91, a 267.54% decline from 2021.
  • Jazz Pharmaceuticals average return on investment for 2021 was 1.14, a 73.67% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Jazz Pharmaceuticals ROI - Return on Investment 2010-2024 | JAZZ

  • Jazz Pharmaceuticals average return on investment for 2023 was 0.76, a 139.79% increase from 2022.
  • Jazz Pharmaceuticals average return on investment for 2022 was -1.91, a 267.54% decline from 2021.
  • Jazz Pharmaceuticals average return on investment for 2021 was 1.14, a 73.67% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.